A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

首次发布于 2016 年 12 月 30 日

CTTI Risk Factors for HABP/VABP Study

计划入组 7,530 人 · 首次发布于 2016 年 2 月 24 日

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

计划入组 133 人 · 首次发布于 2016 年 4 月 5 日

Viritron VPN

HIV specific T-cell therapy

Telavancin(Vibativ)

C₈₀H₁₀₆Cl₂N₁₁O₂₇P · Rx

LADY HARDINGE MEDICAL COLLEGE AND ASSOCIATED HOSPITALS

India

ARMY HOSPITAL RESEARCH AND REFERRAL

India

Herlev and Gentofte Hospital

Denmark

Tabuk Launches Vibativ Antibiotic in Saudi Arabia to Combat Multidrug-Resistant Infections

Cumberland's Vibativ Antibiotic Secures Chinese NMPA Approval for Severe Bacterial Infections

FDA Accepts Shionogi's sNDA for Fetroja (Cefiderocol) in Pediatric Patients with Serious Gram-Negative Infections